Pet owners have become more attuned to pet health and wellness as a result of the COVID-19 pandemic, boosting sales in the pet supplement category, according to market research firm Packaged Facts. Specifically, 41 percent of pet owners are paying closer attention with 14 percent changing the health care products they buy their pets.
Packaged Facts officials estimate that pet supplement sales skyrocketed 21 percent in 2020 to reach nearly $800 million, quadrupling the rate of growth seen in 2019.
“Interest in pet supplements has risen across the board, but condition-specific formulations directly related to COVID-19 concerns, such as those boosting the immune system and offering stress-reducing or anxiety-reducing benefits, have seen demand soar,” said David Sprinkle, research director for Packaged Facts, which is based in Rockville, Md.
Pet anxiety can be brought on by changing habits and schedules, causing pets to exhibit a range of undesirable behaviors and problems for pet owners attempting to work from home, according to officials. Additionally, although the influx of new pets into households has been a welcome distraction for many, new pets can become stressed out while attempting to acclimate to their new environments, officials further noted.
“This state of affairs is occurring at the same time as the mainstreaming of CBD [cannabidiol] products, which are perhaps most famous for their anxiety-reducing properties,” officials said. “CBD is also said to provide anti-inflammatory benefits and aid in immune system regulation, additional spot-on areas of interest in COVID-19 era. Other immune-building supplements often feature probiotics—a cross-over from human supplements that continues to gain momentum in the pet market.”
The findings can be found in Packaged Facts’ November/December 2020 Survey of Pet Owners, which is featured in the new report, Pet Supplements in the U.S., 8th Edition.
For more of PPN's coverage on Packaged Facts reports, read: